Avid Bioservices Inc (CDMO)

[PPHMVERYLONG]

Surprise, surprise I am correct again. This is what I said they would say: "results are promising and we are going to explore how to move the program forward."

This is what the press release said:"Promising Data Presented"
and " warrant further investigation in a larger trial setting."

But no specifics on how to move it forward since almost all the money goes to the Phase III trial. It is not that promising or it would have been licensed already.

Take it from me, it will be 2016 at the earliest before we hear anything that could move the stock price significantly higher.

I said the same thing about 2013 & 2014 and was 100% correct. After fifteen years, I have seen the good, the bad and mostly the ugly.